AdoRx Therapeutics Announces Initial Funding of $10 million for the Discovery of New Cancer Therapeutics
June 21, 2018
Edinburgh, Scotland, 21st June 2018 – AdoRx Therapeutics, a UK based drug discovery company focused on the identification of new cancer therapeutics, today announced that